A prospective Phase 2, single-center, single-allergen OIT of cashew or shrimp in participants
with proven allergies to either cashew or shrimp, respectively. We intend to treat 72
participants, ages 7 to 55 years with an allergy to either cashew, or shrimp determined by
Double Blind-Placebo Controlled-Food Challenge (DBPCFC), allergy history, clinical symptoms,
food-allergen (FA)-specific IgE levels, and skin prick test (SPT).
Phase:
Phase 2
Details
Lead Sponsor:
Kari Christine Nadeau, MD PhD Kari Christine Nadeau, MD, PhD
Collaborator:
National Institute of Allergy and Infectious Diseases (NIAID)